Toolkit for Development & Implementation
How to create a development route
To improve care for patients with cancer, innovation with proven benefits should be implemented in daily practice on large scale. However, innovations do not automatically find their way to practice.
The path from an idea to an innovation in daily practice consists of several steps, with different stakeholders and influencing factors (risks and opportunities). This makes every development path unique and complex. Early insight into this route, stakeholders and other influencing factors will increase the chance of successful implementation.
Valorisation and implementation
IP & potential commercialization
Developing research results into practical applications can be done via the academic route, but also via the commercial route. What suits your invention best?
TTOs and other valorisation experts
Academic institutions usually have Technology Transfer Offices (TTOs) that support researchers with issues related to research applications, intellectual property (IP) and partnering with industry. In addition, there are other parties that can help with the valorisation of your research. On this page we provide information and links to Dutch TTOs and other valorisation experts.
Health Technology Assessment (HTA) is a collective term for the evaluation of the value and costs of novel health care applications and drugs. It serves as an instrument to substantiate whether or not to actually use novel drugs and medical technology.
Reimbursement by health insurers or other parties
When your invention is in use in clinical practice someone will bear the financial costs of its use. But who? Health insurers, hospitals, the patient or another party? Which steps need to be taken to arrange sustainable reimbursement of your invention, and who can help you with that?
Roadmap for drug development
To make new medicinal products available in clinical practice they need to be tested in animal studies and in human clinical trials, registered as medicinal products, and reimbursed by health insurance companies. This is a heavily regulated process. Laws and regulations for medicinal products need to be carefully considered throughout the whole development trajectory.
External parties and useful links
Support in setting up clinical studies - DORP
Clinical trials are crucial for development and validation of novel cancer treatments. DORP can help you in the set-up and conduct of clinical trials. Their services are free of charge.
News flash (June 2023): KWF, IKNL and DORP have jointly decided to discontinue funding for the DORP project, thereby concluding it on 31 December, 2023.
Support in Ethical & Legal matters: ELSI Servicedesk
The National Service Desk, part of Health-RI, helps researchers, other professionals, patients and patient representatives to address Ethical, Legal, Social Implications (ELSI) issues by providing information and advice.
External funding opportunities
KWF is one of the largest cancer research funders in the Netherlands, but other parties also support oncological scientific research & implementation initiatives. We list several funding options that may suit your research idea.